Nebulized Fentanyl for Palliation of Dyspnea in a Cystic Fibrosis Patient

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Respiration

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000081769PMID 15627879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of inhaled morphine on the bronchial response to isocapnic hyperventilation in patients with allergic asthma

  2004cited by this paper
• Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea.

  2002cited by this paper
• Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.

  2002cited by this paper
• Immune-derived opioids and peripheral antinociception.

  2001cited by this paper
• Annual Scientific Meeting of ASCEPT, 1999 Immune‐Derived Opioids And Peripheral Antinociception

  2001cited by this paper
• Opioids for the palliation of breathlessness in terminal illness.

  2001cited by this paper
• Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea.

  2000cited by this paper
• Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease

  2000cited by this paper
• Dyspnea treatment.

  2000cited by this paper
• Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society.

  1999cited by this paper
• Acute respiratory depression as a complication of nebulised morphine

  1998cited by this paper
• End-of-life care in cystic fibrosis.

  1998cited by this paper
• End-of-life care in cystic fibrosis.

  1997cited by this paper
• Care-giver protection from exposure to aerosolized pharmacologic agents. Is it necessary?

  1991cited by this paper
• In vivo evidence for the specific binding of human β-endorphin to the lung and liver of the rat

  1988cited by this paper
• Absorption and bioavailability of nebulized morphine.

  1988cited by this paper
• In vivo evidence for the specific binding of human beta-endorphin to the lung and liver of the rat.

  1988cited by this paper
• Psychophysical bases of perceived exertion.

  1982cited by this paper

• Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl.

  2020cites this paper
• Nebulized Fentanyl for Dyspnea: A Retrospective Chart Review

  2020cites this paper
• Palliative drug treatments for breathlessness in cystic fibrosis.

  2020cites this paper
• Intranasal fentanyl for respiratory distress in children and adolescents with life-limiting conditions

  2018cites this paper
• The use of opioids in the treatment of non-neoplastic pulmonary diseases

  2018cites this paper
• Differential Mechanisms of Dyspnea Relief in Advanced COPD : Opiates vs . Bronchodilators

  2018cites this paper
• Palliative drug treatments for breathlessness in cystic fibrosis.

  2017cites this paper
• Nebulized Fentanyl for Dyspnea in a Hospice Patient with True Allergy to Morphine and Hydromorphone

  2017cites this paper
• Nebulized Fentanyl in Acute Pain

  2016cites this paper
• Drug treatments for breathlessness in end-stage cystic fibrosis

  2015cites this paper
• Nebulized Medications for the Treatment of Dyspnea: A Literature Review

  2015cites this paper
• Inhaled nebulized and intranasal opioids for the relief of breathlessness

  2014cites this paper
• Fentanyl for the relief of refractory breathlessness: a systematic review.

  2013cites this paper
• Symptomerfassung und -therapie

  2013cites this paper
• New formulations of fentanyl for acute pain management.

  2012cites this paper
• Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?

  2012cites this paper
• A symptom-based approach to palliative care in cystic fibrosis

  2011cites this paper
• Supportive and Palliative Care of Advanced Nonmalignant Lung Disease

  2011influential citation
• American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease.

  2010cites this paper
• Local pulmonary opioid network in patients with lung cancer: a putative modulator of respiratory function

  2010cites this paper
• Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients

  2010cites this paper
• Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis.

  2010cites this paper
• Heart Disease Dyspnea in Patients With Advanced Lung or of Consensus Statement on the Management American College of Chest Physicians

  2010cites this paper
• Symptom Management in Children with Cancer

  2009cites this paper
• Dyspnoea in children. Does development alter the perception of breathlessness?

  2009cites this paper
• PAIN RELIEF AND PALLIATIVE CARE IN LEBANON PAIN MANAGEMENT IN CHILDREN WITH T E R M I N A LI L L N E S S E S

  2008cites this paper
• The Role of Inhaled Opioids and Furosemide for the Treatment of Dyspnea

  2007cites this paper
• Pediatric palliative care.

  2005cites this paper
• Pediatric palliative, end-of-life, and bereavement care.

  2005cites this paper